CD74 and cancer: More precisely, MIF downregulated the interaction between cancer-associated fibroblasts and immune cells including B cells, DCs, myeloid derived suppressor cells, monocytes, NK cells, and T cells via the CD74/CD44 and CXCR2/CXCR4 signaling pathways (19–21).